Search





Search





Markets
/
Stocks
/
nasdaq-trax
/

First Tracks Biotherapeutics Ord Shs

TRAX

Add to Watchlist

16.059USD

+0.119+0.75%

Market hours （ET）Quotes delayed by 15 min

558.04MMarket Cap

--P/E TTM



First Tracks Biotherapeutics Ord Shs

16.059

+0.119+0.75%

Overview Financials Discussions Analysis Company

Overview

Financials

Discussions

Analysis

Company

You can find the annual or quarterly income statement of First Tracks Biotherapeutics Ord Shs here for insights into the performance and operational efficiency of First Tracks Biotherapeutics Ord Shs.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

Operating expenses

--52.81M

R&D expenses

--33.95M

Depreciation, depletion, and amortization

--125.00K

Operating profit

---52.81M

Net non-operating interest income (expenses)

Non-operating interest income

--2.33M

Other non-operating income (expenses)

---1.00K

Income before tax

---50.48M

Income after tax

---50.48M

Net income from continuous operations

---50.48M

Net income attributable to controlling interests

---50.48M

Net income attributable to common shareholders

---50.48M

Basic earnings per share

---1.45

Diluted earnings per share

---1.45

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

